![]() InflaRx InflaRx is a biopharmaceutical company developing new therapeutics in the field of acute and chronic inflammation. | ![]() CorMedix CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. | ||||
Founding Date | Founding Date 2006 | Founding Date N/A | Founding Date 1909 | Founding Date 2006 | Founding Date 1995 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Jena, DE HQ Planegg, DE | Locations Ciudad de México, MX HQ | Locations Sant Cugat del Vallès, ES HQ Buenos Aires, AR Clayton South, AU São Paulo, BR Mississauga, CA Las Condes, CL see more | Locations Berkeley Heights, US HQ | Locations Ipswich, GB HQ |
Employees | Employees 74 | Employees 1,0951% increase | Employees 23,800 | Employees 3036% increase | Employees 1293% decrease |
Valuation ($) | Valuation ($) 92.2 m | Valuation ($) N/A | Valuation ($) 6.7 b | Valuation ($) 749.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €29k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €7.5b (FY, 2025) | Revenue (est.) $311.7m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €7.2m (FY, 2025) | Cost of goods N/A | Cost of goods €4.2b (FY, 2025) | Cost of goods $22.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit (€4.5m) (FY, 2025) | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $275.7m (FY, 2025) | Gross profit N/A |
Net income | Net income (€45.6m) (FY, 2025) | Net income N/A | Net income €500m (FY, 2025) | Net income $163.1m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 89m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 11.5m | Total funding raised N/A |
Laboratorio Silanes is a pharmaceutical company.
View company
Grifols is a pharmaceutical and chemical manufacturer.
View company
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
View company
IPRS Group is an organization that provides clinical products and services.
View company